Outset Medical (OM)
Nasdaq Market Open
Outset Medical, Inc. is a medical technology company that develops dialysis systems intended to make treatment simpler to deliver across different care settings. Its core product is Tablo, a haemodialysis platform designed to combine water purification, on-demand dialysate production, touchscreen guidance, and treatment monitoring in a single system. The company’s technology is aimed at reducing the operational complexity traditionally associated with dialysis infrastructure.
Outset Medical sells Tablo consoles and recurring consumables, including cartridges and related accessories used during treatment. The company serves hospitals, health systems, and providers involved in acute and chronic dialysis care, with a particular focus on enabling treatment in more flexible environments. By simplifying setup and workflow, Tablo is designed to support clinicians while also expanding the potential for home-based or decentralised dialysis models where clinically appropriate.
The company operates in a highly regulated healthcare market where purchasing decisions depend on clinical performance, reliability, reimbursement dynamics, training needs, and the economics of care delivery. Dialysis is a large and essential area of treatment for patients with kidney failure, but it is also associated with significant costs and operational demands. Outset Medical’s investment case is closely linked to adoption of its platform, growth in installed systems, utilisation of its consumables, and its ability to demonstrate value to providers seeking more efficient dialysis options. Competition includes established dialysis equipment manufacturers and broader healthcare technology suppliers.
Last updated
- Market Cap
- 85.27M
- P/E
- —
- P/FCF
- —
- P/S
- 0.73
- Enterprise Value
- 151.73M
- Sector
- Health Care
- Industry
- Electromedical and Electrotherapeutic Apparatus
- Address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
Outset Medical to Present at RBC Global Healthcare Conference
Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm
Outset Medical to Present at the 2024 Stifel Healthcare Conference
Outset Partners with User Interviews for Qualitative Research
Outset Medical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. Oct. 28, 2024 Deadline to file Lead Plaintiff Motion
OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
OM DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Outset Medical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)
Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman
ROSEN, A LEADING LAW FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
Outset Medical (OM) Receives Nasdaq Notice, Shares No Longer Meet Minimum Bid Requirement, Class Action Pending After FDA Warning - Hagens Berman
ROSEN, A LEADING LAW FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
OM REMINDER – Robbins LLP Reminds OM Stockholders to Obtain Counsel in Light of the Pending Lead Plaintiff Deadline
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 85.27M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 151.73M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.76
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.73
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -2.39
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.29
- EPS
- -4.04
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -34.25M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -67.02%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -30%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.87
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 6.29
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 4.97
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.81
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 182.76K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 4.6
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 27.86M | 28.87M | 29.43M | 31.42M | 29.75M |
| Gross profit | 12.1M | 12.23M | 11.59M | 11.87M | 11.07M |
| Operating income | -16.92M | -17.63M | -15.81M | -16.87M | -16.4M |
| EBITDA | -16.12M | -16.75M | -14.8M | -15.71M | -15.11M |
| Net income | -18.98M | -19.49M | -17.84M | -18.54M | -25.78M |
| Basic EPS | -1.03 | -1 | -1 | -1.04 | -3.66 |
| Diluted EPS | -1.03 | -1 | -1 | -1.04 | -3.66 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 249.45M | 264.5M | 277.26M | 288.8M | 301.21M |
| Total liabilities | 137.77M | 137.54M | 134.89M | 134.02M | 131.34M |
| Total equity | 111.69M | 126.95M | 142.37M | 154.78M | 169.87M |
| Cash & equivalents | 30.56M | 35.01M | 36.44M | 39.56M | 75.93M |
| Current assets | 236.71M | 250.88M | 265.37M | 275.58M | 286.56M |
| Current liabilities | 37.61M | 37.63M | 37.45M | 36.91M | 34.22M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -12.84M | -9.52M | -6.32M | -4.82M | -25.66M |
| Investing cash flow | 7.9M | 8.59M | 2.97M | -31.16M | -78.08M |
| Financing cash flow | 501K | 0 | 231K | -384K | 55.66M |
| Change in cash | -4.44M | -931K | -3.12M | -36.37M | -48.09M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| edgar index | SD — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Brottem John L. | View Filing | |
| form 4 | Form 4 — Nash Marc | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| edgar index | 10-Q — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Outset Medical, Inc. | View Filing | |
| edgar index | DEFA14A — Outset Medical, Inc. | View Filing | |
| edgar index | 3 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Elliott Derick A. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 3/A — Outset Medical, Inc. | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Brottem John L. | View Filing | |
| form 4 | Form 4 — Nash Marc | View Filing | |
| edgar index | 10-K — Outset Medical, Inc. | View Filing | |
| edgar index | S-8 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 3 — Outset Medical, Inc. | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G — Outset Medical, Inc. | View Filing | |
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Brottem John L. | View Filing | |
| form 4 | Form 4 — Nash Marc | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing |